Hält derzeit Positionen bei Theravance Biopharma Inc, OncoMed Pharmaceuticals Inc and Jazz Pharmaceuticals PLC
Position | Company | Period |
---|---|---|
Chairman of the Board, Chief Executive Officer | Theravance Biopharma Inc | None - |
Director | OncoMed Pharmaceuticals Inc | 24. Juni 2015 - |
Independent Director | Jazz Pharmaceuticals PLC | 1. Mai 2010 - |
Chairman of the Board | Innoviva Inc | 15. August 2014 - 30. Oktober 2014 |
Chairman of the Board, Chief Executive Officer | Innoviva Inc | 1. April 2010 - 15. August 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-15 | 2023-08-14 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
1.241
-10.6%
138,16171.455 USD |
1.241 -10.6% | 138,16 | 171.455 USD | |
2022-12-16 | 2022-12-14 |
Theravance Biopharma Inc
(TBPH)
|
V Verkauf |
50.000
-3.6%
11,19559.500 USD |
50.000 -3.6% | 11,19 | 559.500 USD | |
2022-08-09 | 2022-08-08 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
1.089
-11.2%
152,32165.879 USD |
1.089 -11.2% | 152,32 | 165.879 USD | |
2020-08-10 | 2020-08-07 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
931
-13.1%
125,87117.185 USD |
931 -13.1% | 125,87 | 117.185 USD | |
2018-08-13 | 2018-08-10 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
660
-11.8%
176,61116.563 USD |
660 -11.8% | 176,61 | 116.563 USD | |
2016-08-17 | 2016-08-15 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
633
-4.0%
136,4586.373 USD |
633 -4.0% | 136,45 | 86.373 USD |